Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)
Public ClinicalTrials.gov record NCT00308139. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open-Label, Multicenter, Comparator-Controlled Study to Examine the Effects of Exenatide Long-Acting Release on Glucose Control (HbA1c) and Safety in Subjects With Type 2 Diabetes Mellitus Managed With Diet Modification and Exercise and/or Oral Antidiabetic Medications
Study identification
- NCT ID
- NCT00308139
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 303 participants
Conditions and interventions
Conditions
Interventions
- exenatide Drug
- exenatide, long acting release Drug
Drug
Eligibility (public fields only)
- Age range
- 16 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2006
- Primary completion
- Jun 30, 2008
- Completion
- Jul 31, 2014
- Last update posted
- Aug 25, 2015
2006 – 2014
United States locations
- U.S. sites
- 24
- U.S. states
- 18
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site 182 | Encino | California | 91436 | — |
| Research Site 171 | La Jolla | California | 92037 | — |
| Research Site 518 | San Diego | California | 92161 | — |
| Research Site 024 | Walnut Creek | California | 94598 | — |
| Research Site | Colorado Springs | Colorado | — | — |
| Research Site 057 | Miami | Florida | 33156 | — |
| Research Site | Chicago | Illinois | — | — |
| Research Site 149 | Indianapolis | Indiana | 46254 | — |
| Research Site 099 | Lexington | Kentucky | 40503 | — |
| Research Site 017 | Detroit | Michigan | 48202 | — |
| Research Site 224 | Minneapolis | Minnesota | 55416 | — |
| Research Site 312 | St Louis | Missouri | 63141 | — |
| Research Site 023 | Butte | Montana | 59701 | — |
| Research Site 053 | Rochester | New York | 14609 | — |
| Research Site 002 | Durham | North Carolina | 27713 | — |
| Research Site 123 | Winston-Salem | North Carolina | 27103 | — |
| Research Site 405 | Cincinnati | Ohio | 45219 | — |
| Research Site 557 | Marion | Ohio | 43302 | — |
| Research Site 231 | Portland | Oregon | 97239 | — |
| Research Site 152 | Philadelphia | Pennsylvania | 19146 | — |
| Research Site 587 | Greer | South Carolina | 29651 | — |
| Research Site 015 | Dallas | Texas | 75230 | — |
| Research Site 009 | San Antonio | Texas | 78229 | — |
| Research Site 108 | Olympia | Washington | 98502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00308139, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 25, 2015 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00308139 live on ClinicalTrials.gov.